| HEOTX | RWIBX | HEOTX / RWIBX | |
| Total Expense Ratio | 0.81 | 1.51 | 54% |
| Annual Report Gross Expense Ratio | 0.93 | 1.51 | 62% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 14.025 | 16.460 | 85% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 120M | 156B | 0% |
| Annual Yield % from dividends | 0.50 | 0.71 | 71% |
| Returns for 1 year | 13.08 | 16.18 | 81% |
| Returns for 3 years | 42.96 | 51.06 | 84% |
| Returns for 5 years | 19.06 | 32.74 | 58% |
| Returns for 10 years | 85.11 | 87.54 | 97% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLMOX | 9.72 | 0.10 | +1.04% |
| Harding Loevner Frontier Emerg Mkts Inv | |||
| GGHYX | 44.29 | 0.43 | +0.98% |
| Invesco Health Care Y | |||
| GSILX | 23.00 | 0.10 | +0.44% |
| Goldman Sachs GQG Ptnrs Intl Opps C | |||
| IUAIX | 34.44 | N/A | N/A |
| VY® Invesco Equity and Income I | |||
| FLENX | 51.35 | N/A | N/A |
| Fidelity Advisor® Leveraged CoStock I | |||